Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.78 USD
Change Today +0.21 / 2.77%
Volume 349.6K
SCLN On Other Exchanges
As of 5:20 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary S. Titus CPA

AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Gary S. Titus, CPA, has been the Chief Financial Officer of BioCardia, Inc since May 2014. Mr. Titus served as the Chief Financial Officer and Senior Vice President of Finance at SciClone Pharmaceuticals, Inc. from December 8, 2008 to May 31, 2013 and served as its Principal Accounting Officer until May 31, 2013. He has biotechnology industry and healthcare sectors experience to lead finance activities and investor relations, as well as oversaw human resources, and ...

Read Full Background

Corporate Headquarters*

950 Tower Lane
Foster City, California 94404

United States

Phone: 650-358-3456
Fax: 650-358-3469

Board Members Memberships*

Director, Chairman of Audit Committee, Chairman of Finance Committee, Chairman of Nominating & Governance Committee and Member of Compensation Committee


University of Florida
University of South Florida

Other Affiliations*

Annual Compensation*

Total Annual Compensation$244,231

Stock Options*

Unexercisable Options66,750
Total Number of Options66,750

Total Compensation*

Total Annual Cash Compensation$244,231
Total Short Term Compensation$244,231
Total Calculated Compensation$453,671
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SCLN:US $7.78 USD +0.21


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SCICLONE PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at